MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, OKUR had -$51,711K decrease in cash & cash equivalents over the period. -$51,874K in free cash flow.

Cash Flow Overview

Change in Cash
-$51,711K
Free Cash flow
-$51,874K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Share-based compensation expense
    • Interest income
    • Depreciation and amortization
    • Others
Negative Cash Flow Breakdown
    • Direct program expense
    • Workforce salaries and benefits
    • General corporate expenses
    • Others

Cash Flow
2025-12-31
Direct program expense
28,373
Indirect program expense
1,923
Workforce salaries and benefits
16,301
Share-based compensation expense
11,633
General corporate expenses
4,720
Interest and other expense
8
Interest income
3,441
Adjustments and reconciling items
3,441
Net loss
-59,517
Share-based compensation expense
11,633
Depreciation and amortization
447
Amortization of right-of-use asset - operating
383
Loss on disposal of property and equipment
-6
Prepaid and other assets
-289
Accounts payable, accrued and other liabilities
-4,545
Lease liabilities
-536
Other long-term liabilities
12
Net cash used in operating activities
-51,828
Purchases of property and equipment
46
Net cash (used in) provided by investing activities
-46
Payment of issuance costs associated with the concurrent financing
37
Payment of reverse recapitalization transaction costs
40
Proceeds from sale of stock under the employee stock purchase plan
240
Net cash provided by financing activities
163
Net decrease in cash and cash equivalents
-51,711
Cash and cash equivalents, beginning of period
110,761
Cash and cash equivalents, end of period
59,050
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from sale ofstock under the...$240K Net cash provided byfinancing activities$163K Canceled cashflow$77K Net decrease in cashand cash...-$51,711K Canceled cashflow$163K Share-based compensationexpense$11,633K Depreciation andamortization$447K Amortization of right-of-useasset - operating$383K Prepaid and other assets-$289K Other long-termliabilities$12K Loss on disposal ofproperty and equipment-$6K Interest income$3,441K Payment of reverserecapitalization transaction...$40K Payment of issuancecosts associated with...$37K Net cash used inoperating activities-$51,828K Canceled cashflow$12,770K Net cash (used in)provided by investing...-$46K Adjustments and reconcilingitems$3,441K Net loss-$59,517K Canceled cashflow$3,441K Accounts payable,accrued and other...-$4,545K Lease liabilities-$536K Purchases of property andequipment$46K Direct program expense$28,373K Workforce salaries andbenefits$16,301K Share-based compensationexpense$11,633K General corporateexpenses$4,720K Indirect program expense$1,923K Interest and otherexpense$8K

OnKure Therapeutics, Inc. (OKUR)

OnKure Therapeutics, Inc. (OKUR)